Phibro Animal Health (NASDAQ:PAHC) Upgraded at StockNews.com

Phibro Animal Health (NASDAQ:PAHC) was upgraded by investment analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a report released on Saturday.

A number of other equities research analysts also recently commented on PAHC. JPMorgan Chase & Co. began coverage on Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective for the company. Morgan Stanley lifted their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. Finally, Barclays increased their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Phibro Animal Health presently has a consensus rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Stock Down 1.0 %

Shares of NASDAQ PAHC opened at $20.52 on Friday. The firm’s 50 day moving average price is $23.01 and its 200 day moving average price is $20.99. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. The firm has a market cap of $831.12 million, a P/E ratio of 47.72, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. Phibro Animal Health has a 1 year low of $10.03 and a 1 year high of $25.98.

Institutional Trading of Phibro Animal Health

A number of institutional investors have recently added to or reduced their stakes in PAHC. Acadian Asset Management LLC raised its position in Phibro Animal Health by 6.3% in the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after purchasing an additional 42,299 shares during the period. American Century Companies Inc. raised its holdings in shares of Phibro Animal Health by 119.6% during the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after buying an additional 189,068 shares during the period. Dimensional Fund Advisors LP lifted its position in Phibro Animal Health by 5.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock worth $13,005,000 after acquiring an additional 42,086 shares in the last quarter. Sofinnova Investments Inc. purchased a new position in Phibro Animal Health in the 2nd quarter worth approximately $3,975,000. Finally, Hsbc Holdings PLC acquired a new stake in Phibro Animal Health in the second quarter valued at approximately $238,000. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.